CONTRATOS ART. 60
Contract
A PHASE IV OPEN-LABEL CLINICAL TRIAL TO EVALUATE THE EFFICACY OF IKERVIS ON CLINICAL PARAMETERS AND MOLECULAR/CELLULAR BIOMARKERS IN DRY PATIENTS WITH SEVERE DERATITIS WHO HAVE NOT IMPROVED DESPITE REGULAR USE OF TEAR SUBSTITUTES BEFORE AND AFTER EXPOSURE TO AN ADVERSE CONTROLLED ENVIRONMENT.
Funder:
SANTEN SA
date_range
Duration: from 29 April 2019 to 28 April 2021
(24 months)
euro
60,677.20 EUR
Of European scope.